225 related articles for article (PubMed ID: 33703852)
1. Meta-analysis of impact of renin-angiotensin system inhibitors on survival after transcatheter aortic valve implantation.
Takagi H; Kuno T; Hari Y; Nakashima K; Yokoyama Y; Ueyama H; Ando T;
Minerva Cardiol Angiol; 2021 Jun; 69(3):299-309. PubMed ID: 33703852
[TBL] [Abstract][Full Text] [Related]
2. Impact of renin-angiotensin system inhibitors on outcomes after surgical or transcatheter aortic valve replacement. A meta-analysis.
Amat-Santos IJ; Santos-Martínez S; Julca F; Catalá P; Rodríguez-Gabella T; Redondo-Diéguez A; Hinojosa W; Veras C; Campo A; Serrador Frutos A; Carrasco-Moraleja M; San Román JA
Rev Esp Cardiol (Engl Ed); 2021 May; 74(5):421-426. PubMed ID: 32402685
[TBL] [Abstract][Full Text] [Related]
3. Meta-Analysis for Impact of Statin on Mortality After Transcatheter Aortic Valve Implantation.
Takagi H; Hari Y; Nakashima K; Kuno T; Ando T;
Am J Cardiol; 2019 Sep; 124(6):920-925. PubMed ID: 31326076
[TBL] [Abstract][Full Text] [Related]
4. Effects of renin-angiotensin system inhibitor type and dosage on survival after transcatheter aortic valve implantation.
Fischer-Rasokat U; Bänsch C; Renker M; Rolf A; Charitos EI; Weferling M; Liebetrau C; Herrmann E; Choi YH; Hamm CW; Kim WK
Eur Heart J Cardiovasc Pharmacother; 2022 Dec; 8(8):815-824. PubMed ID: 35441662
[TBL] [Abstract][Full Text] [Related]
5. Impact of renin-angiotensin system blocker after aortic valve replacement-a systematic review and meta-analysis.
Zeng L; Li J; Yang J; Liao Y; Chen M
Ann Palliat Med; 2021 Feb; 10(2):1244-1252. PubMed ID: 33040553
[TBL] [Abstract][Full Text] [Related]
6. Impact of paravalvular aortic regurgitation after transcatheter aortic valve implantation on survival.
Takagi H; Umemoto T;
Int J Cardiol; 2016 Oct; 221():46-51. PubMed ID: 27400296
[TBL] [Abstract][Full Text] [Related]
7. Meta-Analysis of Impact of Baseline N-TerminalPro-Brain Natriuretic Peptide Levels on SurvivalAfter Transcatheter Aortic Valve Implantation for Aortic Stenosis.
Takagi H; Hari Y; Kawai N; Kuno T; Ando T;
Am J Cardiol; 2019 Mar; 123(5):820-826. PubMed ID: 30587374
[TBL] [Abstract][Full Text] [Related]
8. Baseline left ventricular diastolic dysfunction affects midterm mortality after transcatheter aortic valve implantation.
Takagi H; Hari Y; Nakashima K; Yokoyama Y; Ueyama H; Kuno T; Ando T;
J Card Surg; 2020 Mar; 35(3):536-543. PubMed ID: 31886935
[TBL] [Abstract][Full Text] [Related]
9. Worse survival after transcatheter aortic valve implantation than surgical aortic valve replacement: A meta-analysis of observational studies with a propensity-score analysis.
Takagi H; Umemoto T;
Int J Cardiol; 2016 Oct; 220():320-7. PubMed ID: 27390949
[TBL] [Abstract][Full Text] [Related]
10. Optimal Medical Therapy Following Transcatheter Aortic Valve Implantation.
Kaewkes D; Ochiai T; Flint N; Patel V; Mahani S; Kim I; Patel D; Salseth T; Friedman M; Yoon SH; Singh S; Chakravarty T; Nakamura M; Cheng W; Makkar R
Am J Cardiol; 2021 Feb; 141():62-71. PubMed ID: 33221263
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of impact of troponins on mortality after transcatheter aortic valve implantation.
Takagi H; Hari Y; Nakashima K; Kuno T; Ando T;
J Cardiovasc Surg (Torino); 2020 Feb; 61(1):98-106. PubMed ID: 31755678
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of prognostic impact of peripheral arterial disease on mortality after transcatheter aortic valve implantation.
Takagi H; Hari Y; Nakashima K; Kuno T; Ando T;
J Cardiovasc Surg (Torino); 2019 Dec; 60(6):723-732. PubMed ID: 31302953
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibitor for post-transcatheter aortic valve implantation patients: study protocol for a multicenter randomized, open-label blinded endpoint control trial.
Liao YB; Xia C; Cheng Y; Li Q; Wei X; Ou Y; Chen F; Li Y; Liu Q; Xiong T; Zhao Z; Peng Y; Wei J; Feng Y; Chen M
Trials; 2021 Jul; 22(1):462. PubMed ID: 34275476
[TBL] [Abstract][Full Text] [Related]
14. Is the use of renin-angiotensin system inhibitors in patients with aortic valve stenosis safe and of prognostic benefit? A systematic review and meta-analysis.
Andersson C; Abdulla J
Eur Heart J Cardiovasc Pharmacother; 2017 Jan; 3(1):21-27. PubMed ID: 27615013
[TBL] [Abstract][Full Text] [Related]
15. Better midterm survival in women after transcatheter aortic valve implantation.
Takagi H; Umemoto T;
J Cardiovasc Surg (Torino); 2017 Aug; 58(4):624-632. PubMed ID: 27171329
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival after transcatheter versus surgical aortic valve replacement for aortic stenosis: A meta-analysis of observational comparative studies with a propensity-score analysis.
Takagi H; Mitta S; Ando T;
Catheter Cardiovasc Interv; 2018 Aug; 92(2):419-430. PubMed ID: 29388316
[TBL] [Abstract][Full Text] [Related]
17. A meta-analysis of impact of mitral stenosis on outcomes after transcatheter aortic valve implantation.
Takagi H; Hari Y; Nakashima K; Kuno T; Ando T
J Card Surg; 2019 Nov; 34(11):1256-1263. PubMed ID: 31475402
[TBL] [Abstract][Full Text] [Related]
18. Comparison of late mortality after transcatheter aortic valve implantation versus surgical aortic valve replacement: Insights from a meta-analysis.
Ando T; Takagi H;
Eur J Intern Med; 2017 May; 40():43-49. PubMed ID: 28162851
[TBL] [Abstract][Full Text] [Related]
19. Impact of concurrent tricuspid regurgitation on mortality after transcatheter aortic-valve implantation.
Takagi H; Hari Y; Kawai N; Ando T;
Catheter Cardiovasc Interv; 2019 Apr; 93(5):946-953. PubMed ID: 30474201
[TBL] [Abstract][Full Text] [Related]
20. Gait and fate: Baseline gait speed and mortality after transcatheter aortic valve implantation.
Takagi H; Kato M; Hari Y; Nakashima K; Kuno T; Ando T;
J Cardiol; 2020 Jun; 75(6):600-605. PubMed ID: 32098749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
